免疫療法治療薬の世界市場予測(~2021):薬種類別(成人用ワクチン、チェックポイント阻害剤、インターフェロンアルファ)、治療分野別、需要先別、地域別...市場調査レポートについてご紹介

【英文タイトル】Immunotherapy Drugs Market by Type of Drugs (Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha), Therapy Area (Cancer, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals), Region (North America, Asia-Pacific) - Global Forecast to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency ‘
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 30)
4.1 Global Immunotherapy Drugs Market Overview
4.2 Market: By Therapy Area & Region
4.3 Market: Geographic Snapshot
4.4 Market, By Type of Drug
4.5 Life Cycle Analysis, By Region (2016)

5 Market Overview (Page No. – 33)
5.1 Introduction
5.1.1 Drivers
5.1.1.1 Increasing Adoption of Targeted Therapy Over Traditional Therapy
5.1.1.2 Emergence of Biosimilars
5.1.1.3 Increasing Demand for Mabs
5.1.1.4 High Prevalence Rate of Lifestyle Diseases
5.1.1.5 Fast Track and Orphan Drug Designations
5.1.2 Restraints
5.1.2.1 High Cost of Immunotherapy Treatment
5.1.2.2 High Attrition Rate in the Product Development Cycle
5.1.3 Opportunities
5.1.3.1 Emerging Markets
5.1.3.2 Immunotherapy to Replace Chemotherapy in Cancer Treatment
5.1.4 Challenge
5.1.4.1 Impending Patent Expiry of Top-Selling Biologics

6 Industry Insights (Page No. – 39)
6.1 Introduction
6.2 Epidemiology Coverage
6.2.1 Cancer Epidemiology
6.2.2 Autoimmune Disease Epidemiology
6.3 Pricing and Reimbursement Scenario
6.3.1 U.S.
6.3.2 U.K.
6.3.3 France
6.3.4 Germany
6.3.5 Other European Countries
6.3.6 Japan
6.4 Research Funding & Government Initiatives
6.5 Pipeline Drugs
6.5.1 Phase 1
6.5.2 Phase I/II
6.5.3 Phase II
6.5.4 Phase II/III
6.5.5 Phase III
6.5.6 Application Submitted
6.5.7 Promising Molecules
6.6 Industry Trends
6.7 Key Products Expected to Be Launched
6.8 Treatment Protocols and Line of Therapies
6.8.1 First-Line Therapy
6.8.2 Second-Line Therapy
6.8.3 Other Treatments
6.9 Burning Issues

7 Immunotherapy Drugs Market, By Type of Drug (Page No. – 67)
7.1 Introduction
7.2 Monoclonal Antibodies
7.3 Adult Vaccines
7.3.1 Preventive Vaccines
7.3.2 Therapeutic Vaccines
7.4 Checkpoint Inhibitors
7.5 Interferons Alpha & Beta
7.6 Interleukins
7.7 Other Drugs

8 Immunotherapy Drugs Market, By Therapy Area (Page No. – 79)
8.1 Introduction
8.2 Cancer
8.3 Autoimmune and Inflammatory Diseases
8.4 Infectious Diseases
8.5 Other Therapy Areas

9 Immunotherapy Drugs Market, By End User (Page No. – 88)
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Other End Users

10 Immunotherapy Drugs Market, By Region (Page No. – 93)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 116)
11.1 Introduction
11.2 Strategic Analysis
11.3 Market Share Analysis
11.4 Competitive Situation and Trends
11.4.1 Regulatory Approvals
11.4.2 Collaborations
11.4.3 Agreements
11.4.4 Acquisitions
11.4.5 Expansions

12 Company Profiles (Page No. – 124)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 F. Hoffmann-La Roche AG
12.3 Merck & Co., Inc.
12.4 Novartis International AG
12.5 Johnson & Johnson (A Parent Company of Janssen Biotech, Inc.)
12.6 Glaxosmithkline PLC
12.7 Amgen Inc.
12.8 Abbvie
12.9 Astrazeneca
12.10 Bristol-Myers Squibb
12.11 ELI Lilly and Company

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 157)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports
13.8 Author Details


【レポート販売概要】

■ タイトル:免疫療法治療薬の世界市場予測(~2021):薬種類別(成人用ワクチン、チェックポイント阻害剤、インターフェロンアルファ)、治療分野別、需要先別、地域別
■ 英文:Immunotherapy Drugs Market by Type of Drugs (Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha), Therapy Area (Cancer, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals), Region (North America, Asia-Pacific) - Global Forecast to 2021
■ 発行日:2017年1月6日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-PH-3926
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。